CSS LLC’s Albireo Pharma Inc ALBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-53,300
Closed -$1.03M 1213
2022
Q3
$1.03M Buy
+53,300
New +$1.1M 0.05% 340
2022
Q2
Sell
-6,000
Closed -$178K 1340
2022
Q1
$178K Sell
6,000
-500
-8% -$14.6K 0.01% 860
2021
Q4
$151K Hold
6,500
0.01% 951
2021
Q3
$203K Hold
6,500
0.01% 875
2021
Q2
$229K Sell
6,500
-2,000
-24% -$65K 0.01% 823
2021
Q1
$299K Buy
8,500
+6,500
+325% +$240K 0.01% 683
2020
Q4
$75K Sell
2,000
-24,000
-92% -$873K ﹤0.01% 739
2020
Q3
$867K Buy
+26,000
New +$757K 0.04% 318

Other funds holding ALBO

CSS LLC's ALBO Position: Q3 2022 in Review

CSS LLC sold out of Albireo Pharma Inc (ALBO) in Q3 2022, closing a stake of 12,143 shares — an estimated $251K sold.

CSS LLC first reported a position in ALBO in Q4 2020 and held it in 7 quarters. The position peaked at $390K in Q1 2022. 108 funds tracked by Wall St. Rank hold ALBO as of Q3 2022.

  • CSS LLC reported no remaining Albireo Pharma Inc position as of Q3 2022 after selling out during the quarter.
  • CSS LLC sold 12,143 Albireo Pharma Inc shares in Q3 2022, an estimated $251K.
  • CSS LLC first reported a position in Albireo Pharma Inc in Q4 2020 and held it in 7 quarters.
  • CSS LLC's Albireo Pharma Inc position peaked at $390K in Q1 2022.
  • 108 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2022.

Based on CSS LLC's 13F filing for Q3 2022, filed 14 Nov 2022.